Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

GlaxoSmithKline

18 clinical trials · 18 recruiting · INDUSTRY

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by GlaxoSmithKline

RECRUITINGPhase 3NCT06679101

A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus...

The purpose of this Phase 3 study is to evaluate if BRd prolongs progression free survival (PFS) and/or improves minimal residual disease (MRD) negative status compared with DRd...

Sponsor: GlaxoSmithKlineEnrolling: 52020 locations
Multiple MyelomaNewly Diagnosed Multiple Myeloma
RECRUITINGPhase 4NCT06411249

A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus...

This is a prospective, open-label, single arm 3-year clinical study to describe the short-term and long-term efficacy and safety of belimumab in participants with autoantibody...

Sponsor: GlaxoSmithKlineEnrolling: 35020 locations
Systemic Lupus Erythematosus
RECRUITINGNCT06527872

Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN

The purpose of the OBSErve-LN study is to assess the real-world use and effectiveness of belimumab in routine practice for the treatment of adults with active LN in multiple...

Sponsor: GlaxoSmithKlineEnrolling: 3005 locations
Lupus Nephritis
RECRUITINGPhase 3NCT06716606

A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD)...

This is an open label extension (OLE) study of an ongoing randomized controlled parent clinical studies 218224 (NCT05878717) and 221672 (NCT06572384) which aim to assess the...

Sponsor: GlaxoSmithKlineEnrolling: 51410 locations
Connective Tissue Diseases
RECRUITINGPhase 1NCT07358546

A Study of Efimosfermin Alfa in Adults With Hepatic Impairment

This study is designed to study the pharmacokinetic (PK) and safety profiles of a single dose of efimosfermin alfa in participants with varying degrees of Hepatic Impairment (HI)...

Sponsor: GlaxoSmithKlineEnrolling: 322 locations
Non-alcoholic Fatty Liver Disease
RECRUITINGPhase 3NCT07221188

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known...

This study will evaluate the safety and tolerability of Efimosfermin Alfa for participants with known or suspected MASH with fibrosis consistent with stage F2 or F3.

Sponsor: GlaxoSmithKlineEnrolling: 12506 locations
Non-alcoholic Fatty Liver Disease
RECRUITINGPhase 3NCT06979323

Depemokimab Asthma Imaging and Bronchoscopy Sub-Study

Asthma is a chronic condition marked by narrowed and swollen airways due to inflammation leading to recurring symptoms that can vary and worsen unpredictably.\\xa0The purpose of...

Sponsor: GlaxoSmithKlineEnrolling: 1503 locations
Asthma
RECRUITINGPhase 1NCT06154837

A Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease

The primary objective of the study is to investigate the safety and tolerability of ascending doses of GSK3862995B following single dose in healthy participants and repeat doses...

Sponsor: GlaxoSmithKlineEnrolling: 13020 locations
Pulmonary Disease, Chronic Obstructive
RECRUITINGPhase 3NCT06961214

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and...

Depemokimab is being developed as a treatment for individuals with moderate to severe COPD. The aim of this study is to assess the efficacy and safety of depemokimab compared as...

Sponsor: GlaxoSmithKlineEnrolling: 9601 location
Pulmonary Disease, Chronic Obstructive
RECRUITINGPhase 2NCT04954859

Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants...

This is a global multi-center, long-term follow-up study to assess durability of efficacy, as measured by maintenance of treatment response from the parent study, in participants...

Sponsor: GlaxoSmithKlineEnrolling: 45020 locations
Hepatitis B
RECRUITINGPhase 1NCT07168356

A Study to Evaluate Blood Levels of Bepirovirsen in Adult Participants With Severe or Moderate Kidney Disease

This is a 2-part study where all participants will receive bepirovirsen. The study will measure how much bepirovirsen from a single dose gets into the blood, and how long it stays...

Sponsor: GlaxoSmithKlineEnrolling: 321 location
Hepatitis B
RECRUITINGPhase 1NCT06171113

A Study to Investigate the Safety of GSK4024484 in Healthy Adult Participants

The primary purpose of the study is to characterise the safety of GSK4024484 in healthy participants within a controlled pharmacokinetic (PK) range, and the effect of food on the...

Sponsor: GlaxoSmithKlineEnrolling: 1561 location
Malaria, Falciparum
RECRUITINGPhase 2NCT07036159

A Study to Assess the Safety and Immunogenicity of a Vaccine Against Malaria in Healthy Children Aged 5-60 Months

The purpose of this study is to evaluate the safety and immunogenicity of reduced antigen doses and alternative vaccination regimes for RTS,S/AS01E in healthy children aged 5-60...

Sponsor: GlaxoSmithKlineEnrolling: 2382 locations
Malaria
RECRUITINGPhase 3NCT06666491

An Interventional Study to Compare the Efficacy and Safety of Tafenoquine (TQ) and Primaquine (PQ) When Either Are...

The aim of this study is to collect efficacy and safety data to support the registration of tafenoquine in India.

Sponsor: GlaxoSmithKlineEnrolling: 3004 locations
Malaria, Vivax
RECRUITINGPhase 3NCT07220109

A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus Given to Chinese Adults 18 to...

The study will evaluate the immune response of the RSVPreF3 OA investigational vaccine in Chinese adults 18 to 59 years of age (YOA) who are at increased risk of respiratory...

Sponsor: GlaxoSmithKlineEnrolling: 7509 locations
Respiratory Syncytial Virus Infections
RECRUITINGPhase 2NCT07092865

A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and...

This study evaluates persistence of the immune response of the adjuvanted RSV vaccine and the safety and immunogenicity following revaccination in adults 18 years of age and above...

Sponsor: GlaxoSmithKlineEnrolling: 18420 locations
Respiratory Syncytial Virus Infections
RECRUITINGPhase 1NCT07464314

A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults

This early-stage study will look at a new mRNA vaccine that combines defenses against both seasonal flu and COVID-19 in terms of its safety and how it builds protection. Healthy...

Sponsor: GlaxoSmithKlineEnrolling: 2252 locations
Influenza, Human+COVID-19
RECRUITINGPhase 1 / Phase 2NCT06702449

A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and...

The purpose of this study is to assess safety, reactogenicity, and immune response of the candidate UTI vaccine compared to placebo in adults between and including 18-64 years of...

Sponsor: GlaxoSmithKlineEnrolling: 4488 locations
Urinary Tract Infections